Full Breakdown
Supreme Court Weighs Monsanto Liability Over Roundup Cancer Warning
4/25/2026, 11:50:57 PM
Supreme Court Case Over Roundup Warning
On April 27 2026 the Supreme Court heard arguments in a case centered on John Durnell, a park worker awarded $1.25 million after a jury found Roundup’s glyphosate caused his non-Hodgkin lymphoma. The Court must decide whether Monsanto (now Bayer) can be sued for failing to warn of cancer risk. A decision is expected by late June or early July 2026.
Regulatory and Policy Landscape
Roundup, introduced in the 1970s, became the leading herbicide. In 2015 the WHO classified glyphosate as “probably carcinogenic,” but the EPA has never required a cancer warning and its 15-year safety review remains overdue after a 2022 court found inadequate cancer risk assessment. President Donald Trump’s executive order labeled glyphosate a national-security priority and urged production.
Plaintiffs' Experiences
Durnell’s chemotherapy left lasting leg problems; he testified he “is not that physical any longer.” Howard Kornblue, an 84-year-old Scottsdale resident diagnosed with non-Hodgkin lymphoma in 2019, reports immune compromise and limited social activity. Both men are weighing a proposed $7.25 billion class-action settlement that would resolve many claims without awaiting the Court’s ruling.
Corporate and Government Positions
Bayer says EPA assessments find glyphosate non-carcinogenic and that law does not require a warning. The DOJ backs this, citing a cost-benefit analysis that weighs benefits against rare injuries. The American Farm Bureau Federation and other agricultural groups filed an amicus brief asserting glyphosate “revolutionized farming” with control. The Trump administration aligns with Bayer, aiming to protect production and limit liability.
Impact, Criticism, and Opposition
If the Court limits liability, Bayer can keep selling glyphosate to farms; a ruling expanding liability could force a sales halt, which agricultural groups call a “devastating risk to America’s food supply.” Advocates and former EPA officials say EPA labels lack needed warnings and must be updated. Plaintiffs’ attorneys argue the settlement provides insufficient compensation for alleged health harms.
Conflicting Evidence and Gaps
The WHO’s “probably carcinogenic” classification contrasts with the EPA’s repeated conclusions that glyphosate does not cause cancer. The EPA’s overdue safety review leaves the scientific consensus uncertain, a point highlighted by former EPA officials and the DOJ.
Verbatim Quotes
- “I don’t trust the Supreme Court in this situation,” — Howard Kornblue, user
- “Walmart gives a better warning to people when they have a spill of milk in the store than Monsanto's ever given to a Roundup lawn and garden buyer,” — Roe Frazer, attorney
- “He can no longer help improve his neighborhood because, he told the jury that heard his lawsuit, “I’m not that physical any longer.” — John Durnell, plaintiff
- “My situation will never get better,” he said.” — Howard Kornblue, user
Outlook and Next Steps
Plaintiffs must decide whether to join the $7.25 billion settlement before the Supreme Court issues its opinion. Lawmakers are also considering legislation that could shield glyphosate manufacturers from liability. The Court’s ruling will shape the regulatory landscape for herbicides and influence the balance between agricultural productivity and consumer safety.
